Results 231 to 240 of about 31,515 (266)

Fluconazole therapy in transplant recipients under FK506 therapy [PDF]

, 1994
Gonzalez-Pinto, I, Jain, A, Kusne, S, Manez, R, Martin, M, Silverman, D, Starzl, TE, Venkataramanan, R, Warty, V   +8 more
core  

Antifungal prophylaxis during antibiotic therapy.

Indian journal of medical sciences, 1966
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antifungal prophylaxis in neutropenia

Current Opinion in Infectious Diseases, 1999
Despite the widespread prophylactic use of antifungal agents in neutropenic patients, invasive fungal infections continue to emerge as major causes of morbidity and mortality. With the exception of fluconazole prophylaxis in allogeneic marrow transplant recipients, no firm conclusions can be drawn due to the lack of reliable, randomized trials.
J A, Maertens, M A, Boogaerts
openaire   +2 more sources

Antifungal prophylaxis in neonates

Early Human Development, 2011
Fungal-related morbidity and mortality is a major concern for most neonatal intensive care units (NICUs) worldwide. Incidence rates are increasing and might be higher than reported due to the challenges associated with diagnosing fungal infections. As preterm neonates display clinical characteristics that make them prone to Candida spp infections, and ...
Manzoni P, Jacqz Aigrain E, Rizzollo S, Franco C, Stronati M, MOSTERT, Michael Martin, Farina D.   +6 more
openaire   +2 more sources

Antifungal Prophylaxis in Immunocompromised Hosts

Annals of Pharmacotherapy, 1993
OBJECTIVE: To review the literature on the efficacy and safety of antifungal agents for prophylaxis of fungal infections in populations of immunocompromised hosts (key words: hematology-oncology, surgical, solid organ transplant, HIV infection), and to develop guidelines and recommendations regarding safe and effective drug regimens for antifungal ...
S, Reents, S D, Goodwin, V, Singh
openaire   +2 more sources

Pharmacotherapy approaches to antifungal prophylaxis

Expert Opinion on Pharmacotherapy, 2012
Invasive fungal infection (IFI) is a serious problem due to difficulties in early diagnosis and high mortality. Different approaches are adopted for the treatment and management of IFI, including prophylactic, empiric, preemptive and directed strategies.This paper reviews the type of pharmacotherapy used for antifungal prophylaxis in infants with ...
Tzi Bun, Ng, Randy Chi Fai, Cheung, Xiu juan, Ye, Evandro Fei, Fang, Yau Sang, Chan, Wen Liang, Pan, Xiu Li, Dan, Cui Ming, Yin, Sze Kwan, Lam, Peng, Lin, Patrick Hung Kui, Ngai, Li Xin, Xia, Fang, Liu, Xiu Yun, Ye, He Xiang, Wang, Jack Ho, Wong   +15 more
openaire   +2 more sources

Antifungal prophylaxis in lung transplantation

International Journal of Antimicrobial Agents, 2014
Lung transplant (LTx) patients have an increased risk of developing invasive fungal infections (IFIs), particularly invasive aspergillosis. Rapid identification of the causative fungal pathogen, to allow for early administration of appropriate initial antifungal therapy, in LTx patients has been challenging due to the limited sensitivity and ...
Chin Fen, Neoh, Greg, Snell, Bronwyn, Levvey, C Orla, Morrissey, Kay, Stewart, David C M, Kong   +5 more
openaire   +2 more sources